LECONASIA
Skip to content
  • Home
  • About
  • Testimonials
  • News
  • Contact

From the Bench to Biotech Venture Capital – Newswise

Posted on December 18, 2021 by admin
From the Bench to Biotech Venture Capital  Newswise
Bookmark the permalink.

Post navigation

← Super Money Moves: Philly’s top investment rounds of 2021, its best year for VC dollars yet – Technical.ly
Why Venture Capital Investors Are Focused on Femtech – Sidley Austin LLP →

Recent Posts

  • 4 Reasons The Venture Capital Boom Is Damaging Entrepreneurs’ Mental Health – Forbes
  • Tennis Australia’s New Venture Capital Arm Follows NFL’s Lead – Sportico.com
  • Are venture capital’s go-go years about to end? – PitchBook News & Analysis
  • U.S. Venture Capital Activity Soars to New Highs in 2021 as Deal Value Exceeds $300 Billion and Fundraising Tops $100 Billion – Daily Record-News
  • U.S. venture capital deals notched all-time high of $330 billion in 2021 – Reuters
  • U.A.E. Sovereign-Wealth Fund Invests $100 Million in Israel Venture-Capital Firms – The Wall Street Journal
  • FTX launches $2 billion venture fund, hires Lightspeed exec to lead – The Block Crypto
  • SoftBank, Sequoia Capital China Help Push Asia Venture Funding To New Heights – Crunchbase News
  • How ‘Litquidity’ went from finance meme influencer to Bain Capital Ventures’ newest scout – Fortune
  • NVCA: U.S venture capital deals soar past $300B in 2021 – VentureBeat
Singapore Office:
21 Bukit Batok Crescent
#09-79 WCEGA Tower
Singapore 658065
Korea Office:
1432 Seocho LG Eclat Banpo-daero
14-gil 71, Seocho-gu Seoul,
Republic of Korea
For Regional Support:
[email protected]

For Sales & Marketing:
[email protected]

LECON ASIA
Copyrights © 2015
All Rights Reserved

www.leconasia.com

Zerif Lite developed by ThemeIsle